Search hospitals

>

North Carolina

>

Wilmington

Novo Nordisk Investigational Site

Claim this profile

Wilmington, North Carolina 28401

Global Leader in Type 2 Diabetes

Global Leader in Diabetes

Conducts research for Obesity

Conducts research for Hemophilia

Conducts research for Congenital Hematological Disorder

270 reported clinical trials

0 medical researchers

Photo of Novo Nordisk Investigational Site in WilmingtonPhoto of Novo Nordisk Investigational Site in WilmingtonPhoto of Novo Nordisk Investigational Site in Wilmington

Summary

Novo Nordisk Investigational Site is a medical facility located in Wilmington, North Carolina. This center is recognized for care of Type 2 Diabetes, Diabetes, Obesity, Hemophilia, Congenital Hematological Disorder and other specialties. Novo Nordisk Investigational Site is involved with conducting 270 clinical trials across 68 conditions. There are 0 research doctors associated with this hospital, such as .

Area of expertise

1

Type 2 Diabetes

Global Leader

Novo Nordisk Investigational Site has run 133 trials for Type 2 Diabetes. Some of their research focus areas include:

Stage II
Stage I
2

Diabetes

Global Leader

Novo Nordisk Investigational Site has run 124 trials for Diabetes.

Top PIs

Clinical Trials running at Novo Nordisk Investigational Site

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Novo Nordisk Investigational Site?